Current NDC auxiliary source row compounder:4077

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69852-517
Product Ndc: 69852-517
Product Ndc Digits: 69852517
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Semaglutide 2.4 mg/mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Semaglutide 2.4 mg/mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Eagle Pharma Outsourcing, LLC
Establishment Name: Eagle Pharma Outsourcing, LLC
Establishment Fei: [empty]
Substance Name: SEMAGLUTIDE
Active Ingredients Info: 2.4 mg/2.4 mg
History Active Ingredients Raw: SEMAGLUTIDE
History Active Ingredients Info Raw: 2.4 mg/2.4 mg
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 69852-517-05
Package Ndc: 69852-517-05
Package Ndc Digits: 6985251705
Package Ndc11: 69852051705
Package Description: 12 mg in 1 VIAL, MULTI-DOSE (69852-517-05)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4077
Source Row Number: 4077
Source Row Hash: 83d82bc8141c19ed709e902ef19d596c57ed1a07648e5630aa3693988bee4876
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "SUBCUTANEOUS",
    "PRODUCTNDC": "69852-517",
    "DEASCHEDULE": "",
    "LABELERNAME": "Eagle Pharma Outsourcing, LLC",
    "SUBSTANCENAME": "SEMAGLUTIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "69852-517-05",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Semaglutide 2.4 mg/mL",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Semaglutide 2.4 mg/mL",
    "PACKAGEDESCRIPTION": "12 mg in 1 VIAL, MULTI-DOSE (69852-517-05) ",
    "ACTIVEINGREDIENTSINFO": "2.4 mg/2.4 mg",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4077
Source Row Number: 4077
Status Scope: package
Lookup Ndc: 69852-517-05
Lookup Ndc Digits: 6985251705
Product Ndc: 69852-517
Product Ndc Digits: 69852517
Package Ndc: 69852-517-05
Package Ndc Digits: 6985251705
Package Ndc11: 69852051705
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 83d82bc8141c19ed709e902ef19d596c57ed1a07648e5630aa3693988bee4876
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33